Yun-Jung Choi
5PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 14, 2025
Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in Mice.Edward E Cable, Jeffrey W Stebbins, Jeff D Johnson
|Dec 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield
|Nov 28, 2023
Seladelpar combined with complementary therapies improves fibrosis, inflammation, and liver injury in a mouse model of nonalcoholic steatohepatitis.Yun-Jung Choi, Jeff D Johnson, Jin-Ju Lee
|Oct 31, 2023
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.Marlyn J Mayo, John M Vierling, Christopher L Bowlus
|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein
Pageof 1
Frequent Collaborators
4 joint publications
Charles A McWherter
3 joint publications
Gideon M Hirschfield
3 joint publications
Cynthia Levy
3 joint publications
Marlyn J Mayo
3 joint publications
Christopher L Bowlus
2 joint publications
Mitchell L Shiffman
2 joint publications
John M Vierling
2 joint publications
Andreas E Kremer
2 joint publications
Richard J Aspinall
2 joint publications
Stuart C Gordon
